Enterprise Value
1.132B
Cash
125.1M
Avg Qtr Burn
-10.76M
Short % of Float
3.96%
Insider Ownership
9.39%
Institutional Own.
44.37%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
APG777 Details Atopic dermatitis | Phase 1 Data readout |